EpiPen maker Mylan pays executives too much, some big investors say as they fight back
(LA Times MLB)

Put off by what they see as exorbitant pay for Mylan executives, some big pension funds are attempting to block the reelection of a number of board members, including Chairman and former Chief Executive Robert Coury, who received $100 million last year. They say huge paychecks were awarded to executives...